Endoscopy 2015; 47(S 01): E2-E3
DOI: 10.1055/s-0034-1377400
Cases and Techniques Library (CTL)
© Georg Thieme Verlag KG Stuttgart · New York

Diminutive submucosally invasive cancers of the colon and rectum

Autoren

  • Kinichi Hotta

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Kenichiro Imai

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Yuichiro Yamaguchi

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Noboru Kawata

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Masaki Tanaka

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Naomi Kakushima

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Kohei Takizawa

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Hiroyuki Matsubayashi

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
  • Hiroyuki Ono

    Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
20. Januar 2015 (online)

Only a few cases of submucosally invasive colorectal cancer (SM-CRC) in diminutive colorectal polyps of ≤ 5 mm have been described [1], and as yet there is no detailed knowledge of these cancers.

Pathological SM-CRCs were selected from our colonoscopy database. We examined the frequency of these lesions relative to all colonoscopy examinations and to colorectal neoplasms ≤ 5 mm. The growth type of the lesions was divided into two categories: polypoid growth and non-polypoid growth [2].

A total of 32 692 colonoscopies were performed between September 2002 and December 2012, from which 5690 colorectal neoplasms were detected and treated. Only seven cases of SM-CRC occurred in lesions ≤ 5 mm, accounting for only 0.5 % (7/1358) of colorectal neoplasms ≤ 5 mm.

Baseline patient information, endoscopic and pathological findings, and outcomes are summarized in [Table 1]. Four cases were of protruded type and three cases were of depressed type. All the protruded-type lesions were initially diagnosed before treatment as being adenomas and were resected endoscopically. All the depressed-type lesions were diagnosed before treatment as being malignant. Endoscopic treatment was indicated for six of the patients (#1 – #6), and additional surgery was performed for two patients (#1 and #2) because of histological findings that suggested a high metastatic risk. All cases were of pathologically well-differentiated adenocarcinomas of non-polypoid growth type. No lymph node metastasis was evident in the surgically resected cases. The appearances in patients #2 and #3 are shown in [Fig. 1] and [Fig. 2] respectively.

Tab. 1

Baseline patient data, endoscopic and pathological findings, and outcomes of seven patients with diminutive submucosally invasive colorectal cancers.

Patient number

sex; age

Tumor location; type; size, mm

Endoscopic diagnosis

Treatment

Pathological diagnosis

Resection margin

Growth type

Invasion depth, μm

ly

v

pN

Metastatic risk

Outcome

1

M; 67

Ascending colon; Ip; 5

Adenoma

Polypectomy then surgery

Adenocarcinoma (tub1)

Negative

Non-polypoid

1750

0

1

0

High

Lost to follow-up

2

M; 85

Transverse colon; Is; 5

Adenoma

EMR then surgery

Adenocarcinoma (tub1)

Negative

Non-polypoid

1750

0

0

0

High

Alive, disease free

3

M; 76

Transverse colon; Is; 5

Adenoma

EMR

Adenocarcinoma (tub1)

Negative

Non-polypoid

 300

0

0

N/A

Low

Alive, disease free

4

F; 86

Rectosigmoid; Is; 4

Adenoma

EMR

Adenocarcinoma (tub1)

Negative

Non-polypoid

1370

0

0

N/A

High

Alive, disease free

5

M; 57

Sigmoid colon; IIc; 5

Intramucosal cancer

EMR

Adenocarcinoma (tub1)

Negative

Non-polypoid

 250

0

0

N/A

Low

Alive, disease free

6

M; 53

Sigmoid colon; IIc; 5

Intramucosal cancer

EMR

Adenocarcinoma (tub1)

Negative

Non-polypoid

 200

0

0

N/A

Low

Alive, disease free

7

F; 61

Sigmoid colon; IIa + IIc; 5

Submucosal invasive cancer

Surgery

Adenocarcinoma (tub1)

N/A

Non-polypoid

3500

1

0

0

High

Alive, disease free

ly, lymphatic permeation; v, vascular permeation; pN, pathological lymph node metastasis; M, male; F, female; tub1, well-differentiated tubular adenocarcinoma; EMR, endoscopic mucosal resection; N/A, not applicable.

Zoom
Fig. 1 Images from patient #2. a Conventional colonoscopy showing a protruded lesion (5 mm in diameter) in the transverse colon. b Chromoendoscopy obtained using an indigo carmine spray showing an indistinct depressed area surrounding a protrusion. c Pathology of the specimen from endoscopic mucosal resection (EMR) showing submucosal invasive cancer (1750 µm) of non-polypoid growth type.
Zoom
Fig. 2 Images from patient #3. a Conventional colonoscopy showing a protruded lesion (5 mm in diameter) in the transverse colon. b Chromoendoscopy obtained using an indigo carmine spray showing an indistinct depressed area surrounding a protrusion. c Pathology of the specimen from endoscopic mucosal resection (EMR) showing submucosally invasive cancer (300 μm) of non-polypoid growth type.

The most important finding of the present study was that all diminutive SM-CRCs were pathologically diagnosed as being of non-polypoid growth type. Shimoda et al. [2] reported that colorectal cancers showing non-polypoid growth tended to invade the submucosa when of a smaller size than those showing polypoid growth. Chromoendoscopy, magnified endoscopy, and image-enhanced endoscopy have been shown to be effective for the precise diagnosis of invasion depth in colorectal cancers [3] [4]. Careful endoscopic observation is strongly recommended when adopting the policies of the DISCARD trial [5] [6].

Endoscopy_UCTN_Code_CCL_1AD_2AB